Table 2.
Dispensed medication data for patients aged ≥45 years with diagnoses of AF and chronic heart failure (n=7,975) in primary care attending the 75 PHCCs between January 1st 2001 and December 31st 2007
| Men and women (n=7,975) | |||
|---|---|---|---|
| No CHF N=6,423 | CHF during follow-up N=1,552 (19.5%) | Difference Age-adjusted | |
| Digitalis (C01A) | 1,800 (28.0) | 581 (37.4) | <0.001 |
| Any diuretic treatment (C03) | 3,758 (58.5) | 1,098 (70.8) | <0.001 |
| Thiazides (C03A, C03B, C03E, C09B C09DA) | 2,067 (32.2) | 387 (24.9) | <0.001 |
| Loop diuretics (C03C) | 2,358 (36.7) | 867 (55.9) | <0.001 |
| Aldosterone antagonists (C03DA) | 522 (8.1) | 193 (12.4) | <0.001 |
| All beta blockers (C07) | 5,028 (78.3) | 1,083 (69.8) | <0.001 |
| Beta1-selective agents (C07AB, C07F) | 4.582 (71.3) | 962 (62.0) | <0.001 |
| Non-selective beta blockers (C07AA) | 1,199 (18.7) | 208 (13.4) | 0.038 |
| Calcium channel blockers (C08) | 2,362 (36.8) | 459 (29.6) | <0.001 |
| Heart active (C08D) | 380 (5.9) | 78 (5.0) | 0.61 |
| Vessel selective (C08C, C09DB) | 2,061 (32.1) | 393 (25.3) | <0.001 |
| RAS-blocking agents (C09) | 3,101 (51.7) | 800 (51.6) | 0.10 |
| ACE inhibitors (C09A, C09B) | 2,366 (36.8) | 558 (36.0) | 0.55 |
| ARB (C09C, C09D) | 1,617 (25.2) | 349 (22.5) | 0.40 |
| Statins (C10AA) | 2,443 (38.0) | 440 (28.4) | <0.001 |